Rooney CM - Search Results

1

Adenovirus as an emerging pathogen in immunocompromised patients.

Leen AM, Rooney CM. Leen AM, et al. Among authors: rooney cm. Br J Haematol. 2005 Jan;128(2):135-44. doi: 10.1111/j.1365-2141.2004.05218.x. Br J Haematol. 2005. PMID: 15638847 Free article. Review.

2

Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas.

Liu Z, Savoldo B, Huls H, Lopez T, Gee A, Wilson J, Brenner MK, Heslop HE, Rooney CM. Liu Z, et al. Among authors: rooney cm. Recent Results Cancer Res. 2002;159:123-33. doi: 10.1007/978-3-642-56352-2_15. Recent Results Cancer Res. 2002. PMID: 11785836

3

Immunotherapy for post-transplant lymphoproliferative disease.

Straathof KC, Savoldo B, Heslop HE, Rooney CM. Straathof KC, et al. Among authors: rooney cm. Br J Haematol. 2002 Sep;118(3):728-40. doi: 10.1046/j.1365-2141.2002.03594.x. Br J Haematol. 2002. PMID: 12181039 Free article. Review. No abstract available.

4

Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection.

Savoldo B, Huls MH, Liu Z, Okamura T, Volk HD, Reinke P, Sabat R, Babel N, Jones JF, Webster-Cyriaque J, Gee AP, Brenner MK, Heslop HE, Rooney CM. Savoldo B, et al. Among authors: rooney cm. Blood. 2002 Dec 1;100(12):4059-66. doi: 10.1182/blood-2002-01-0039. Epub 2002 Aug 1. Blood. 2002. PMID: 12393655 Free article. Clinical Trial.

5

Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications.

Leen AM, Sili U, Savoldo B, Jewell AM, Piedra PA, Brenner MK, Rooney CM. Leen AM, et al. Among authors: rooney cm. Blood. 2004 Feb 1;103(3):1011-9. doi: 10.1182/blood-2003-07-2449. Epub 2003 Oct 2. Blood. 2004. PMID: 14525768 Free article.

6

Adoptive immunotherapy for posttransplantation viral infections.

Bollard CM, Kuehnle I, Leen A, Rooney CM, Heslop HE. Bollard CM, et al. Among authors: rooney cm. Biol Blood Marrow Transplant. 2004 Mar;10(3):143-55. doi: 10.1016/j.bbmt.2003.09.017. Biol Blood Marrow Transplant. 2004. PMID: 14993880 Free article. Review.

7

Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells.

Leen AM, Sili U, Vanin EF, Jewell AM, Xie W, Vignali D, Piedra PA, Brenner MK, Rooney CM. Leen AM, et al. Among authors: rooney cm. Blood. 2004 Oct 15;104(8):2432-40. doi: 10.1182/blood-2004-02-0646. Epub 2004 Jul 20. Blood. 2004. PMID: 15265797 Free article.

8

Cellular therapy of Epstein-Barr-virus-associated post-transplant lymphoproliferative disease.

Heslop HE, Savoldo B, Rooney CM. Heslop HE, et al. Among authors: rooney cm. Best Pract Res Clin Haematol. 2004 Sep;17(3):401-13. doi: 10.1016/j.beha.2004.05.007. Best Pract Res Clin Haematol. 2004. PMID: 15498712 Review.

9

Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphoma.

Straathof KC, Leen AM, Buza EL, Taylor G, Huls MH, Heslop HE, Rooney CM, Bollard CM. Straathof KC, et al. Among authors: rooney cm. J Immunol. 2005 Sep 15;175(6):4137-47. doi: 10.4049/jimmunol.175.6.4137. J Immunol. 2005. PMID: 16148164

10

T-cell immunotherapy for adenoviral infections of stem-cell transplant recipients.

Leen AM, Myers GD, Bollard CM, Huls MH, Sili U, Gee AP, Heslop HE, Rooney CM. Leen AM, et al. Among authors: rooney cm. Ann N Y Acad Sci. 2005 Dec;1062:104-15. doi: 10.1196/annals.1358.013. Ann N Y Acad Sci. 2005. PMID: 16461793 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

343 results

Search Page

Filters